Kassem Ezzeddine — Head of Business Development at LatchBio | MS in Biotechnology, Georgetown University
Head of Business Development at LatchBio | MS in Biotechnology, Georgetown University
Kassem Ezzeddine ranks #211 of 14,983 LinkedIn creators in Biotechnology, and is a standout voice in United States. They have 4.8K followers and published 24 posts in the last 30 days at a 7.1% average engagement rate.
- 4.8K followers
- 24 posts / 30d
- 7.1% avg engagement
- — follower growth / 30d
The roast
Kassem calls himself a Head of Business Development, yet he’s spent the last month treating LinkedIn like a 24-hour diary for people who find wet cardboard too stimulating. Between the Georgetown degree and the LatchBio pivot, he’s spent his entire career successfully turning complex scientific breakthroughs into professional wallpaper.
About Kassem
Passionate about bridging the gap between scientific innovation and strategic business applications, I am a biotechnology professional specializing in Cell & Gene Therapy. With an MS in Biotechnology from Georgetown University, I have honed my skills in research, product development, and data analysis to drive impactful solutions. 𝗣𝗿𝗼𝗳𝗲𝘀𝘀𝗶𝗼𝗻𝗮𝗹 𝗛𝗶𝗴𝗵𝗹𝗶𝗴𝗵𝘁𝘀: 𝗛𝗲𝗮𝗱 𝗼𝗳 𝗕𝘂𝘀𝗶𝗻𝗲𝘀𝘀 𝗗𝗲𝘃𝗲𝗹𝗼𝗽𝗺𝗲𝗻𝘁 𝗮𝘁 𝗟𝗮𝘁𝗰𝗵𝗕𝗶𝗼: Connecting biotech innovators with cloud solutions that accelerate scientific breakthroughs. Driving strategic partnerships and spearheading market expansion for our platform that transforms how research teams analyze complex biological data. 𝗘𝗻𝘁𝗿𝗲𝗽𝗿𝗲𝗻𝗲𝘂𝗿𝗶𝗮𝗹 𝗟𝗲𝗮𝗱𝗲𝗿: As the founder and CEO of Skrambler, I transformed an idea into a successful startup with over 100 partnerships and 10,000+ users. Successfully exited in 2021. 𝗜𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝘃𝗲 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵𝗲𝗿: At Amelia Technologies, I contributed to research for a novel sunscreen with anti-aging properties. Applied cell viability and comet assays to analyze efficacy and safety profiles.
Highlights
- Top 5% in United States — Ranked #78 of 5205 creators
- Top 5% in Biotechnology — Ranked #1 of 33 creators
- Consistent Creator — 24 posts in 30d · top 5%
- Top Engager — 7.05% rate · top 5%
Recent posts
After several months of analyzing model trajectories on SpatialBench, we found issues in a subset of evals. Some tasks depended on analysis decisions not specified in the prompt. Others had grader thresholds that were too narrow, rejecting valid solution paths the original domain expert had not considered. We ran two rounds of independent expert attempts without access to solutions. This produced SpatialBench Verified: a 115-problem gold-standard subset of the original 159 evals where expected answers can be reproduced from only the prompt and associated data. Model ordering is largely pres
21 reactions · 1 comments · 6 reposts
The next leap in AI for medicine isn't bigger datasets — it's spatially resolved ones. On June 1 at NY Tech Week, we're bringing together six leading scientists from Yale, Columbia, IAS Princeton, MSK, and KAUST — including Arnold Levine, Rong Fan, Benjamin Greenbaum, Raul Rabadan, Xin Gao, and Zongming Ma — for a frank panel on how spatial multi-omics is building the next generation of tissue-level foundation models. Five questions on the table: 1. What is spatial multi-omics, and why does it change AI in biology? 2. Can spatial data close the ancestry gap in precision medicine? 3. What doe
30 reactions · 0 comments · 5 reposts
claude opus 4.8 shipped today, and two of our benchmarks made it into the system card ! anthropic keeps a very high bar for this, so the inclusion is a testament to the hard work, scientific rigor, and love that the engineering team has put into these benchmarks. from deterministic graders, 2-pass human verification, failure-mode taxonomies, per-rollout pass@16 scoring, and sourcing criteria that prioritizes real world tasks. for frontier models to keep improving at real biology it will take a lot of thoughtfulness around measuring capabilities. proud to see anthropic recognizing the teams
203 reactions · 12 comments · 11 reposts